Current Opinion in Biomedical Engineering

Papers
(The H4-Index of Current Opinion in Biomedical Engineering is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
AAV-based CRISPR-Cas9 genome editing: Challenges and engineering opportunities54
Bioresorbable vascular metallic scaffolds: Current status and research trends54
Toward the use of muscle reinnveration for chronic bidirectional control of prostheses to improve functional outcomes of end users49
Editorial Board49
Using biophysical cues and biomaterials to improve genetic models47
Brainy biomaterials: Latest advances in smart biomaterials to develop the next generation of neural interfaces42
Smart orthopedic biomaterials and implants41
Porous microneedles: Transdermal salt bridge for biomedical device engineering40
The prospect of electroceutical intervention and its implementation toward intractable neuromuscular diseases39
Integrating in vitro disease models of the neurovascular unit into discovery and development of neurotherapeutics39
Defining omics-based biomarker signatures of metabolic dysfunction-associated steatotic liver disease (MASLD): In vitro studies35
Developing patient-centric specifications for autologous chimeric antigen receptor T cell therapies33
Recent advances in gene therapy for cancer theranostics33
Contents32
Outlook in tissue-engineered magnetic systems and biomagnetic control31
Emerging trends of discrete Poly(ethylene glycol) in biomedical applications28
Design of biocompatible and self-antibacterial titanium surfaces for biomedical applications26
Biophysical determinants of nuclear shape and mechanics and their implications for genome integrity25
AI models for protein design are driving antibody engineering25
Mining microbial organisms to discover and characterize novel CRISPR-Cas systems25
Editorial overview: Scaffold-based and scaffold-free approaches for mechanobiology, in vitro disease modeling and treatment22
Biomaterial nanocarrier-driven mechanisms to modulate anti-tumor immunity21
0.028329133987427